Sign inJoin waitlistJoin the waitlist

PG

Patrick Grogan

Physician · H. Lee Moffitt Cancer Center and Research Institute

Credentials: · · · · · ·

History

H. Lee Moffitt Cancer Center and Research Institute
2023–Present

Medical Oncology
2019–2021
Internal Medicine
University of Wisconsin Hospitals and Clinics
2016–2019
Univ of Kansas Sch of Med
2012–2016

Research

Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
Neuro-Oncology · 2009 · 327 citations
Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response
Clinical Cancer Research · 2006 · 219 citations
Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel
Molecular Cancer Therapeutics · 2007 · 164 citations

Jann Sarkaria
11 papers
Mark Cohen
9 papers
Mark Schroeder
8 papers · 7 as a fellow
CG
Caterina Giannini
6 papers
HR
H Robins
4 papers
Dustin Deming
3 papers
SH
Steven Howard
3 papers
Arnold Etame
2 papers
BA
Brian Andersen
2 papers
Bruce Blazar
2 papers
CB
Catherine Boldig
2 papers · 2 as a resident
Ekokobe Fonkem
2 papers

Clinical trials

A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
Site PI · Recruiting · Phase 1
Tetragon Biosciences Ltd
2026–2027
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Site PI · Recruiting · Phase 1, Phase 2
National Cancer Institute (NCI)
2023–2027
Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMD
Sub-investigator · Recruiting · Phase 2
H. Lee Moffitt Cancer Center and Research Institute
2026–2030